The effectiveness of extracorporeal shock wave therapy and wrist splint for management of carpal tunnel syndrome
Phase 3
- Conditions
- carpal tunnel syndrome.carpal tunnel syndrome
- Registration Number
- IRCT2014083118991N1
- Lead Sponsor
- Iran University Of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients 18-70 years of age; tingling and numbness or hand pain more than 1 month; vas equal or more than 4; positive tinel's sign or phalen's test; confirmed mild to moderate carpal tunnel syndrome by electrophysiological study.
Exclusion criteria: severe carpal tunnel syndrome; pregnancy; previous carpal tunnel decompression surgery in affected hand; corticosteroid injection to the carpal tunnel within last 3 months; history of wrist fracture in affected hand; abnormal EDX findings except carpal tunnel syndrome such as radiculopathy or polyneuropathy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tingling and pain intensity. Timepoint: before beginning treatment, 3, 8 and 12 weeks after treatment. Method of measurement: visual analog scale.;Severity of symptoms and functional status. Timepoint: before beginning treatment, 3, 8 and 12 weeks after treatment. Method of measurement: persian quick DASH questionnaire.;Sensory and motor distal latency and amplitude of median nerve. Timepoint: Before beginning treatment, 3, 8 and 12 weeks after treatment. Method of measurement: EDX evaluating (nerve Conduction Study).
- Secondary Outcome Measures
Name Time Method Any side effect after intervention. Timepoint: during ESWT therapy, 3, 8 and 12 weeks after therapy. Method of measurement: Ask from patient.